DXN

TINA.org investigated DXN (or Daxen, Inc.) as part of a larger investigation into atypical income claims used by MLM companies. To read more about TINA.org’s 2023 MLM Income Claims Investigation, click here.


How We Took Action

2024
September 26

Pursuant to its own monitoring of the direct selling industry and a TINA.org investigation, the DSSRC issues a fourth case decision against the company, this one finding that it uses atypical earnings claims to market its business opportunity.

February 14

As part of its 2023 investigation into 100 MLM companies, TINA.org notifies DXN (also known as Daxen) of its findings that the company has used atypical income claims to market its business opportunity.

2023
May 25

The DSSRC issues a third case decision finding that the company continued to use unsubstantiated health claims to market products.

2022
April 4

The DSSRC issues a second case decision finding that the company continued to use unsubstantiated health claims to market products.

2021
November 10

The DSSRC issues a case decision finding that the company used unsubstantiated health claims to market products.

October 26

The FTC sends DXN (also known as Daxen) a Notice of Penalty Offenses Concerning Money-Making Opportunities putting the company on formal notice that it is an unfair or deceptive trade practice to misrepresent that profits or earnings are the ordinary, typical or average profits or earnings made by participants, and to fail to disclose conditions affecting income, such as expenses borne by the participants, among other things

June 30

TINA.org sends a letter, along with a list of more than 660 direct selling companies that includes DXN (also known as Daxen), to the FTC urging it to implement a penalty offense program targeting the direct selling industry and its market-wide practice of using deceptive earnings representations and false health claims.


The Latest

Filters